Literature DB >> 24255056

Protein kinase G I and heart failure: Shifting focus from vascular unloading to direct myocardial antiremodeling effects.

Qingwu Kong1, Robert M Blanton.   

Abstract

Entities:  

Keywords:  cardiac remodeling, ventricular; congestive heart failure; cyclic GMP-dependent protein kinase

Mesh：

Substances：

Year:  2013        PMID： 24255056      PMCID： PMC4213067          DOI： 10.1161/CIRCHEARTFAILURE.113.000575

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN： 1941-3289            Impact factor:   8.790


× No keyword cloud information.
  91 in total

Review 1.  The biology of cyclic GMP-dependent protein kinases.

Authors:  Franz Hofmann
Journal:  J Biol Chem       Date:  2004-11-15       Impact factor: 5.157

2.  Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.

Authors:  Anne L Taylor; Susan Ziesche; Clyde Yancy; Peter Carson; Ralph D'Agostino; Keith Ferdinand; Malcolm Taylor; Kirkwood Adams; Michael Sabolinski; Manuel Worcel; Jay N Cohn
Journal:  N Engl J Med       Date:  2004-11-08       Impact factor: 91.245

3.  Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiotoxicity.

Authors:  Patrick W Fisher; Fadi Salloum; Anindita Das; Haroon Hyder; Rakesh C Kukreja
Journal:  Circulation       Date:  2005-04-05       Impact factor: 29.690

4.  Defective smooth muscle regulation in cGMP kinase I-deficient mice.

Authors:  A Pfeifer; P Klatt; S Massberg; L Ny; M Sausbier; C Hirneiss; G X Wang; M Korth; A Aszódi; K E Andersson; F Krombach; A Mayerhofer; P Ruth; R Fässler; F Hofmann
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

5.  Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy.

Authors:  Eiki Takimoto; Hunter C Champion; Manxiang Li; Diego Belardi; Shuxun Ren; E Rene Rodriguez; Djahida Bedja; Kathleen L Gabrielson; Yibin Wang; David A Kass
Journal:  Nat Med       Date:  2005-01-23       Impact factor: 53.440

6.  Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load.

Authors:  Eiki Takimoto; Hunter C Champion; Manxiang Li; Shuxun Ren; E Rene Rodriguez; Barbara Tavazzi; Giuseppe Lazzarino; Nazareno Paolocci; Kathleen L Gabrielson; Yibin Wang; David A Kass
Journal:  J Clin Invest       Date:  2005-04-14       Impact factor: 14.808

7.  Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials.

Authors:  Jonathan D Sackner-Bernstein; Marcin Kowalski; Marshal Fox; Keith Aaronson
Journal:  JAMA       Date:  2005-04-20       Impact factor: 56.272

8.  The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure.

Authors:  Marco Guazzi; Gabriele Tumminello; Fabio Di Marco; Cesare Fiorentini; Maurizio D Guazzi
Journal:  J Am Coll Cardiol       Date:  2004-12-21       Impact factor: 24.094

9.  Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload.

Authors:  Hartmut Ruetten; Stefanie Dimmeler; Doris Gehring; Christian Ihling; Andreas M Zeiher
Journal:  Cardiovasc Res       Date:  2005-02-24       Impact factor: 10.787

10.  Angiotensin II-induced hypertrophy of adult rat cardiomyocytes is blocked by nitric oxide.

Authors:  R H Ritchie; R J Schiebinger; M C LaPointe; J D Marsh
Journal:  Am J Physiol       Date:  1998-10
View more
  15 in total

Review 1.  From bedside to bench--meeting report of the 7th International Conference on cGMP "cGMP: generators, effectors and therapeutic implications" in Trier, Germany, from June 19th to 21st 2015.

Authors:  Andreas Friebe; Peter Sandner; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-10-20       Impact factor: 3.000

2.  CRRL269.

Authors:  Yang Chen; Gail J Harty; Ye Zheng; Seethalakshmi R Iyer; Shinobu Sugihara; S Jeson Sangaralingham; Tomoko Ichiki; Joseph P Grande; Hon-Chi Lee; Xiaoli Wang; John C Burnett
Journal:  Circ Res       Date:  2019-05-10       Impact factor: 17.367

3.  Molecular Screen Identifies Cardiac Myosin-Binding Protein-C as a Protein Kinase G-Iα Substrate.

Authors:  Robrecht Thoonen; Shewit Giovanni; Suresh Govindan; Dong I Lee; Guang-Rong Wang; Timothy D Calamaras; Eiki Takimoto; David A Kass; Sakthivel Sadayappan; Robert M Blanton
Journal:  Circ Heart Fail       Date:  2015-10-18       Impact factor: 8.790

4.  I Kid(ney) You Not...Natriuretic Peptides Which Promote Natriuresis but Not Hypotension.

Authors:  Robert M Blanton
Journal:  Circ Res       Date:  2019-05-10       Impact factor: 17.367

5.  Sacubitril/Valsartan Improves Left Ventricular Function in Chronic Pressure Overload Independent of Intact Cyclic Guanosine Monophosphate-dependent Protein Kinase I Alpha Signaling.

Authors:  Kelly Tam; Daniel A Richards; Mark J Aronovitz; Gregory L Martin; Suchita Pande; Iris Z Jaffe; Robert M Blanton
Journal:  J Card Fail       Date:  2020-05-25       Impact factor: 5.712

Review 6.  Priming the proteasome by protein kinase G: a novel cardioprotective mechanism of sildenafil.

Authors:  Hanming Zhang; Xuejun Wang
Journal:  Future Cardiol       Date:  2015-03

7.  Prevention of PKG-1α Oxidation Suppresses Antihypertrophic/Antifibrotic Effects From PDE5 Inhibition but not sGC Stimulation.

Authors:  Taishi Nakamura; Guangshuo Zhu; Mark J Ranek; Kristen Kokkonen-Simon; Manling Zhang; Grace E Kim; Kenichi Tsujita; David A Kass
Journal:  Circ Heart Fail       Date:  2018-03       Impact factor: 8.790

8.  Cardiac unloading by LVAD support differentially influences components of the cGMP-PKG signaling pathway in ischemic and dilated cardiomyopathy.

Authors:  Sven Persoon; Michael Paulus; Stephan Hirt; Carsten Jungbauer; Alexander Dietl; Andreas Luchner; Christof Schmid; Lars S Maier; Christoph Birner
Journal:  Heart Vessels       Date:  2018-03-15       Impact factor: 2.037

9.  CRD-733, a Novel PDE9 (Phosphodiesterase 9) Inhibitor, Reverses Pressure Overload-Induced Heart Failure.

Authors:  Daniel A Richards; Mark J Aronovitz; Peiwen Liu; Gregory L Martin; Kelly Tam; Suchita Pande; Richard H Karas; Daniel M Bloomfield; Michael E Mendelsohn; Robert M Blanton
Journal:  Circ Heart Fail       Date:  2021-01-19       Impact factor: 8.790

Review 10.  cGMP Signaling and Modulation in Heart Failure.

Authors:  Robert M Blanton
Journal:  J Cardiovasc Pharmacol       Date:  2020-05       Impact factor: 3.271
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.